Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors - Aix-Marseille Université Access content directly
Journal Articles International Journal of Cancer Year : 2020

Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors

Jimmy Stalin
Wael Traboulsi
  • Function : Author
  • PersonId : 775166
  • IdRef : 219516014
Lucie Vivancos‐stalin
  • Function : Author
Marie Nollet
  • Function : Author
Ahmad Joshkon
Richard Bachelier
Benjamin Guillet
  • Function : Author
Romaric Lacroix
Alexandrine Foucault‐bertaud
  • Function : Author
Françoise Dignat‐george
Nathalie Bardin
Marcel Blot‐chabaud

Dates and versions

hal-03504360 , version 1 (29-12-2021)

Identifiers

Cite

Aurelie Leroyer, Jimmy Stalin, Wael Traboulsi, Lucie Vivancos‐stalin, Marie Nollet, et al.. Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors. International Journal of Cancer, 2020, 147 (6), pp.1666-1679. ⟨10.1002/ijc.32909⟩. ⟨hal-03504360⟩
15 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More